FRE Ann: Firebrick Pharma's Phase 3 Trial of Nasodine Resumes - 21st Mar 2023, 8:42am

annb0t

annb0t

Top 20
FRE Ann: Firebrick Pharma's Phase 3 Trial of Nasodine Resumes
Price Sensitive: Y
Date: 21st Mar 2023, 8:42am

>>> Read announcement: Google: FRE Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
FRE Ann: Firebrick Receives $1.81m R&D Tax Incentive - 31st Oct 2023, 9:06am
Replies
0
Views
140
annb0t
annb0t
annb0t
FRE Ann: Firebrick Phase 3 Trial Closes with 500 Subjects - 9th Aug 2023, 9:04am
Replies
0
Views
125
annb0t
annb0t
annb0t
FRE Ann: Firebrick Covid-19 Trial Achieves Primary Endpoint - 7th Aug 2023, 8:16am
Replies
0
Views
110
annb0t
annb0t
annb0t
FRE Ann: Firebrick Update on AAT Process - 20th Jul 2023, 8:24am
Replies
0
Views
151
annb0t
annb0t
annb0t
FRE Ann: Firebrick Update on Phase 2 Trial Results - 12th Jul 2023, 5:04pm
Replies
0
Views
171
annb0t
annb0t
Top Bottom